Guangzhou University of Chinese Medicine, Guangzhou 510000, Guangdong, China.
Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou510000, Guangdong, China.
Comb Chem High Throughput Screen. 2021;24(7):957-967. doi: 10.2174/1386207323666201001114101.
Novel coronavirus pneumonia (NCP), or coronavirus disease 2019 (COVID-19), is a worldwide health threat that has affected millions of people globally. Traditional Chinese medicine (TCM) has been introduced for the treatment of COVID-19. However, efficacy differs among herbal medicines, and the ideal prescription pattern for TCM herbal formulae for COVID-19 treatment needs to be explored. Therefore, the data mining method has been used in this study to analyze the TCM prescription pattern for COVID-19.
The aim of this study was to analyze the TCM prescription pattern in Regional Schemes in China for COVID-19 in order to provide a new reference for the use of TCM in COVID-19 treatment.
By searching the TCM treatment protocols of COVID-19 in 23 Regional Schemes, TCM syndromes and herbal medicines were analyzed by data mining. The Ancient and Modern Medical Case Cloud Platform (V2.1 personal Edition) was used to perform frequency statistics, correlation analysis, and cluster analysis. A total of 82 TCM syndromes and 171 Chinese herbal medicines were found. The course of the disease can be divided into the early stage, middle stage, severe stage, and recovery stage.
In the early stage, the focus is primarily on resolving dampness, dispelling cold, and diffusing the lungs. In the middle stage, the treatment priority is clearing heat and resolving toxins, promoting lung function, and relieving asthma. In the severe stage, the focus is on tonifying Qi, restoring Yang, and relieving the depletion of Yin and Yang. In the recovery stage, the main treatment is to invigorate the spleen and regulate Qi, tonify Qi, nourish Yin, and clear residual disease. There are certain differences between the Regional Schemes and the Nation Schemes, but the core prescription pattern of the former is consistent with the latter. The effectiveness of these 171 Chinese herbs include but are not limited to inhibiting COVID-19, strengthening immune system function, preventing heart failure, acting as antioxidants, oxidative stress inhibitory effects, maintaining organ function, and improving leukocyte survival.
This study may help to improve understanding of TCM herbal prescription pattern, practices, reveal the efficacy of combinations of Chinese herbs, and provide new ideas for TCM treatment for COVID-19.
新型冠状病毒肺炎(NCP),又称 2019 年冠状病毒病(COVID-19),是一种全球性的健康威胁,已影响到全球数百万人。中医药已被引入 COVID-19 的治疗中。然而,草药的疗效存在差异,需要探索 COVID-19 中医药治疗的理想方剂模式。因此,本研究采用数据挖掘方法分析 COVID-19 的中医药处方模式。
本研究旨在分析中国区域方案中 COVID-19 的中医药处方模式,为 COVID-19 的中医药治疗提供新的参考。
通过检索 23 个区域方案中 COVID-19 的中医药治疗方案,采用数据挖掘方法分析中医证候和中药。使用古今医案云平台(V2.1 个人版)进行频率统计、关联分析和聚类分析。共发现 82 种中医证候和 171 种中草药。疾病过程可分为早期、中期、重症期和恢复期。
早期主要以祛湿散寒、宣肺为主;中期以清热解毒、宣肺平喘为主;重症期以益气回阳、阴阳两虚为主;恢复期以健脾调气、益气养阴、清余邪为主。区域方案与国家方案存在一定差异,但前者的核心处方模式与后者一致。这 171 种中草药的功效不仅包括抑制 COVID-19、增强免疫系统功能、预防心力衰竭、作为抗氧化剂、抑制氧化应激、维持器官功能、提高白细胞存活率等。
本研究可能有助于提高对中医药处方模式、实践的认识,揭示中草药组合的功效,为中医药治疗 COVID-19 提供新思路。